WO1999039629A1 - Capteurs chimiques a systemes de microflux - Google Patents

Capteurs chimiques a systemes de microflux Download PDF

Info

Publication number
WO1999039629A1
WO1999039629A1 PCT/US1999/002493 US9902493W WO9939629A1 WO 1999039629 A1 WO1999039629 A1 WO 1999039629A1 US 9902493 W US9902493 W US 9902493W WO 9939629 A1 WO9939629 A1 WO 9939629A1
Authority
WO
WIPO (PCT)
Prior art keywords
sensing
fluid
reagent
micro
sensor
Prior art date
Application number
PCT/US1999/002493
Other languages
English (en)
Inventor
Bruce C. Towe
Original Assignee
Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University filed Critical Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting For And On Behalf Of Arizona State University
Publication of WO1999039629A1 publication Critical patent/WO1999039629A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14525—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using microdialysis
    • A61B5/14528—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using microdialysis invasively
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
    • A61B5/686—Permanently implanted devices, e.g. pacemakers, other stimulators, biochips

Definitions

  • the present invention relates generally to chemical sensors used to measure the concentration of a specific chemical or gas dissolved within a fluid, and more particularly, to biochemical sensors and continuous monitoring systems including these sensors which have increased stability and longer useful life.
  • the concentration of a specific chemical, such as glucose, in a solution can be measured in a variety of ways.
  • benchtop instruments and clinical automated analyzers often use dye-based color spectrophotometric tests for glucose and other biochemicals.
  • a commonly used color test for glucose is the Trinder test, which is commercially available from the at the Sigma Chemical Co., located in St. Louis, Missouri. This test relies on a reaction between the enzyme glucose oxidase, ambient oxygen, and glucose in a sample to provide a hydrogen peroxide intermediate which initiates a color change in an associated dye system.
  • a sample of blood plasma is introduced into a cuvette containing the reagent, and the glucose concentration is measured by correlating the resulting change in spectrophotometer absorbance at 500 nm to absorbance readings of known glucose concentration standards.
  • most of the present benchtop or autoanalyzer methods for measuring the concentration of chemicals, such as glucose are not suited to continuous monitoring in protein-bearing environments.
  • Commercially available benchtop instruments can typically only measure a single processed sample at a time.
  • these devices either (i) require the user to calibrate the instrument before use, which is labor and time intensive, or (ii) include automatic self-calibration mechanisms, typically before each measurement, which introduces added complexity to the instrument.
  • thermal enzyme monitoring technologies employing enzyme coated and non-enzyme coated probes
  • thermal eddies exist which can give rise to an apparent temperature differential between the enzyme-coated and non-enzyme coated probes irrespective of the concentration of the chemical under test.
  • Such thermal eddies may give rise to false indications of concentrations of the chemical under test, or alternatively, may tend to offset temperature differentials which would otherwise be present due to the chemical reaction of the chemical under test.
  • the most stringent requirements placed on sensors are those intended for biomedical implantable applications. Attempts at implantable sensors for glucose have been under development for nearly thirty years, stemming from the work of Leland Clark in the 1960's. It is recognized that a successful implantable sensor would relieve the diabetic from the constant chore of pricking himself to obtain blood for external testing.
  • the difficulties and constraints on the performance of implantable sensors are particularly severe.
  • thermopile based calorimetric biochemical sensor described in U.S. Patent No. 4,935,534, issued to Guilbeau et al., which is incorporated herein by reference.
  • These sensors employ an enzyme as a method of catalyzing a reaction producing a local exothermic heat of reaction which is indicative of the concentration of the substrate-chemical.
  • enzyme degradation can reach a threshold where the catalyzed chemical reactions fail to produce the nominal heat of the reaction.
  • the sensor loses its calibration and its sensitivity to the target-chemical with continued enzyme degradation. High loadings of the enzyme and selective membranes placed over the enzyme can slow the loss of sensor sensitivity. However, the sensor will ultimately become inoperable.
  • decay of the sensing substance is a major lifetime limiting factor for implantable sensors.
  • enzyme decay generally limits the lifetime of any implantable enzyme-based sensor system to a duration of typically less than about a month.
  • Such a short sensor life makes long- term implantation impractical, since the patient would have to undergo unnecessary surgery to frequently remove or replace the sensor.
  • transcutaneous sensors employing microdialysis principles for sampling tissue glucose, as described in Keck et al., "Combination of Microdialysis and Glucosensor Permits Continuous (on line) s.c. Glucose Monitoring in a Patient Operated Device: I In Vitro Evaluation," Horm. Metab.
  • Microdialysis is a method of sampling the biochemical environment of complex fluids, such as in tissue and blood has been known since the 1980's. It is a process where a sweep fluid is passed through a thin membrane hollow fiber (also referred to as "microdialysis fiber") that is in contact with the solution being tested.
  • a sweep fluid is passed through a thin membrane hollow fiber (also referred to as "microdialysis fiber") that is in contact with the solution being tested.
  • These fibers are well characterized in terms of biocompatibility as a result of their use in kidney dialysis. They are typically made of biocompatible materials, such as cellulose acetate, polysulfone, and polyacrylonitrile, usually in the form of hollow tubes on the order of 200 microns in diameter.
  • the membrane qualities of the hollow fiber allow the transport of glucose and other low molecular weight materials (typically below about 10,000 wt.) across its walls and so, given sufficient time, a sweep fluid passing through the fiber will achieve diffusive equilibrium with the environment. Proteins, red hemoglobin, and blood formed elements in which the fiber is immersed are excluded from the sweep fluid.
  • the emerging sweep fluid from the fiber is actually a dialysate having a clear color.
  • the dialysate has the same concentration of glucose as the environment as long as the flow velocity of the sweep fluid within the fiber is low enough to permit time for equilibrium.
  • Transcutaneous approaches to blood glucose measurement by microdialysis have typically interfaced the microdialysis fiber with variations of the enzyme- amperometric glucose sensor.
  • Fiber optic catheter-type gas sensors for oxygen and carbon dioxide have been receiving increased attention due to their potentially small sensing tip and rugged construction, as described in Wolfbeis, et al., "Fiber Optic Fluorosensor for Oxygen and Carbon Dioxide," Anal. Chem.. 60:2018 (1988); Wolfbeis et al.,
  • Fiber optic gas sensors typically use silicone or TEFLON membranes to entrap a small, fixed quantity of a gas sensitive reagent at the tip of the fiber. Due to the limited amount of reagent that can be practically immobilized at the end of the fiber, these gas sensors are susceptible to problems of leaching, dilution, and gradual loss of activity of the reagent over a short period time, typically just a few days. Other problems are caused by photobleaching of the fixed amount of reagent which is immobilized on the fiber tip. Photobleaching is caused by repeated exposure to intense ultraviolet color excitation from quartz or mercury arc lamps, which are typically used in photodetection systems. Yet another problem is the lack of a sufficient amount of light ultimately entering the photodetector at the remote end of the fiber. This inadequate amount of fransmittance can contribute to sensor signal-to-noise ratio problems.
  • an object of the present invention to provide a long-term stable, continuously monitoring, sensing system for measuring the concentration of chemical species in a fluid.
  • the system includes a micro-flow reservoir system having at least one micro-flow reservoir including a reagent fluid which reacts with the target chemical and a sensor for detecting the occurrence of the reaction connected to the micro-reservoir system by a conduit which conveys fluid from the micro-flow reservoir system to the sensor.
  • the sensing system can be implanted in a sample host.
  • the sensor includes a thermopile which measures heat resulting from the reaction of the reagent and target chemical.
  • the sensor includes an optical cell which measures a change in the optical properties of the reagent when contacted with the target chemical. This arrangement has been found to be useful as a biochemical sensor for use in continuous monitoring systems requiring sensing systems which are stable over long time periods and capable of measuring target chemicals including gases in a fluid.
  • Figure 1 is a schematic of a sensing system including a thermopile in accordance with the invention
  • Figure 2 A is an illustration of a top view of a containment system in a micro-flow reservoir of the sensing system in accordance with the invention
  • Figure 2B is an illustration of a side view of a micro-flow reservoir including multiple collapsible bags in accordance with the invention
  • FIG. 3 is a schematic of a thermopile used in a sensing system in accordance with the invention.
  • Figure 4 is an illustration of an implantable sensing system in accordance with the invention wherein the reservoir is refillable through a septum and remote from the sensor;
  • Figure 5 is a schematic of a sensing system including an optical cell in accordance with the invention.
  • Figure 6 is a schematic of a sensing system for detecting the presence of a gas in accordance with the invention
  • Figure 7 is an illustration of an optical cell for use in a sensing system in accordance with the present invention
  • FIG. 8 is a schematic of an implantable microfluidic glucose sensor in accordance with the invention. -10-
  • Figure 9 is a schematic of a sensing arrangement including a vascular graft in accordance with the invention.
  • Figure 10A and 10B are illustrations of vascular graft arrangements for use in the invention
  • Figure 11 is a graph illustrating the correspondence of measured glucose concentration versus true blood glucose concentration for a sensing system having a vascular graft in accordance with the invention
  • Figure 12 is a graph of extraction fraction of glucose versus residence time for a sensing arrangement including a vascular graft in accordance with the invention.
  • Figure 13 is a graph illustrating absorbance versus different mixing ratios of Trinder reagent and glucose at different concentrations
  • Figure 14 is a graph of fraction of glucose in a dialysate versus test media as a function of perfusate residence time;
  • Figure 15 is a graph of output voltage from a photodetector versus CO 2 concentration;
  • Figure 16 is a graph of output voltage from a photodetector versus glucose concentration.
  • sensing systems of the present invention combine various sensor technologies with a means for renewing or replacing the sensing-substance which eventually decays within a short period of time, typically within a week or two months.
  • Sensing-substance means any substance which is needed to facilitate a measurable reaction with the target chemical.
  • Target chemical means the particular chemical, biochemical, or gas for which the concentration measurement is being made.
  • the sensing-substance can be an -11-
  • Long-term stability means (i) continuous operation for greater than about 5 months, preferably greater than about 6, more preferably greater than about 8 months, and most preferably greater than about 12 months, without replacing the sensor or replenishing the sensing-substance, and (ii) minimized long-term drift in measurement readings, preferably less than 30%, more preferably less than 25%, most preferably less than 10%.
  • the long-term stable, chemical and gas sensing systems of the present invention include (i) a micro-flow reagent reservoir, (ii) a sensor fluidly connected to the micro-flow reagent reservoir, and optionally (iii) a waste reservoir fluidly connected to the sensor.
  • a sensing system in accordance with the invention is shown in Figure 1.
  • the sensing system includes a micro-flow reservoir system 10, a sensor system 80A fluidly connected to the micro-flow reservoir system 10 and a waste reservoir 140 fluidly connected to the sensor system 80 A.
  • the sensing system is immersed or implanted in a sample host, for example glucose containing blood.
  • the micro-flow reservoir system includes a reservoir 10a which contains fresh reagents, and a reservoir 10b including calibration solutions needed for calibrating the sensor system 80A.
  • Each micro-flow reservoir may also contain a sweep solution.
  • Each micro-flow reservoir is capable of providing extremely low but continuous flow rates, preferably from about 1 nanoliter/min. to about 1 microliter/min, more preferable from about 10 nanoliter/min. to about 100 nanoliter/min. These micro-flow rates allow the sensing arrangement 80A to be operational for a long period of time, e.g., greater than 5 months.
  • the flow rate for a specific reagent, calibration solution, and/or sweep solution will depend on the -12-
  • micro-flow system well known to one skilled in the art may be used so long as it is capable of providing extremely low but continuous flow rates (e.g., on the order of nanoliters/min.), several nonlimiting embodiments are provided hereinafter.
  • micro-flow reagent reservoir 10a An exploded view of micro-flow reagent reservoir 10a is shown in Fig. 2B.
  • the micro-flow reagent reservoir 10a includes housing or containment 10c and a collapsible bag 20 for holding the reagent solution.
  • a tubing arrangement has an open ended tubing portion 30 arranged in a curled position inside the bag 20 and tubing portion 50 located outside the bag 20 which connects the reservoir 10a to the sensor system 80 A.
  • the tubing portion 30 may be wrapped as a coil around a collapsible bag and housed within the containment.
  • the reservoir 10b includes an additional reagent bag 21 that contains a calibration solution 70 which is insensitive to the concentration of the target-chemical, thereby allowing calibration of the sensor.
  • the reagent bag may contain a dilute solution of hydrogen peroxide that, when perfused through the membrane fiber 90, will locally diffuse out of it and come into contact with the catalase activity in blood thereby producing a heat of known value. This heat effect will allow calibration of the thermopile 80 and verification of its operation.
  • the reservoirs 10a and 10b can be pressurized with an inert gas, such as nitrogen or a fluorocarbon propellant, such as those used in commercial aerosol dispensers for paint.
  • the collapsible bags can be made of any inert polymeric material known to one skilled in the art, e.g., MYLAR or TEFLON.
  • the collapsible bags 20, 21 are fluidly connected at the open end to resistance tubing 30 which is typically made of an inert and impermeable material, e.g., silica based capillary microbore tubing, which is commercially available from Polymicro -13-
  • Microbore tubing is understood by those skilled in the art to be tubing having an inner diameter of less than about 100 ⁇ m. Typically, the tubing arrangement has an inner diameter of about 25 microns or less and a length on the order of about one meter.
  • This chemical system 60 is then loaded into the collapsible bag 20, hereinbefore described.
  • This bag communicates with resistance tubing 30, typically having an inner diameter of 25 microns or less and a length on the order of one meter.
  • the sensor system 80A includes a hollow membrane fiber 90, typically having an inner diameter of about 200 microns in diameter, bonded, typically with silicone adhesive or other bonding material well known in the art, onto the surface of a thermopile sensor 80 in place of an enzyme gel or other process which normally entraps a fixed amount of enzyme.
  • These membrane fibers are well known in the art as microdialysis tubing, which is commercially available from Enka, Inc., Scientific Systems, located in Lexington, Massachusetts. Being semipermeable, these hollow membrane fibers have a specific molecular weight cutoff (typically below about 10,000 wt. by weight average) which prevents the -14-
  • thermopile size two or more loops of the hollow fiber may be needed to completely cover the thermopile sensing junctions, i.e., 100, 102, 104, 106, 108, 112, and 114 as shown in Fig. 3.
  • the membrane hollow fibers used are preferably among those well characterized in terms of their blood biocompatibility and typically made of materials such as cellulose acetate, polysulfone, and polyacrylonitrile, usually in the form of hollow tubes having an inner diameter of about of 200 microns.
  • thermopile 80 Upon contact of the target sample with the reagent solution a chemical reaction ensues within the lumen of the membrane fiber 90, and the thermopile 80 senses the reaction heat.
  • the thermopile sensor 80 of the type described herein may use a reagent fluid including the enzyme glucose oxidase to catalyze the chemical reaction of glucose and may further include the enzyme catalase for causing the further chemical decomposition of hydrogen peroxide into water and oxygen gas, resulting in the liberation of additional amounts of heat.
  • a sensor may also utilize a reagent fluid including enzymes and any associated co-factors, as listed below, in order to detect and measure concentrations of the corresponding chemicals:
  • glucose dehydrogenase and co-factor NADP for detecting glucose concentrations
  • cholesterol oxidase for measuring concentrations of cholesterol
  • thermopiles for use in the invention include, but are not limited to, the thermopiles described in U.S. Patent No. 4,935,345 issued to Guilbeau et al, which is incorporated by reference herein.
  • An exploded view of the thermopile 80 is shown in Fig. 3. As illustrated in Fig. 3, this thin film thermopile 80 functions by producing a differential voltage induced by a temperature differential between the sensing junctions (e.g., 100, 102, 104, 106, 108, 112, and 114) and the reference junctions (e.g., 101, 103, 105, 107, 109, and 113).
  • the heat of reaction, or the heat of metabolism, resulting from the reaction of the sensing- substance and the target-chemical initiated in the vicinity of the sensing junctions creates a temperature differential between the sensing junctions and the reference junctions which induces a differential voltage thereacross.
  • Appropriate lead wires are connected to the output terminals of the thermopile 110 and 111 for providing the voltage difference signal to amplifiers 120 and 121 and then to the microcontroller 130 which associates the magnitude of the differential voltage to a concentration of the target chemical.
  • This system replenishes the enzyme to the reaction zone by providing new enzyme solution into membrane fiber at extremely low but uninterrupted flow rates.
  • the flow is chosen to be the minimum which is just sufficient to offset the decay rate of the enzyme. This varies according to a particular enzyme, but for glucose oxidase can be in the range of about 10 nanoliters per minute, depending on the method of preserving the enzyme activity. This flow rate allows a 5 ml reservoir of enzyme to supply the sensor for nearly a year of operation.
  • the membrane fiber can be returned by microbore tubing to recover the decayed chemical system for storage within a separate compartment having a lower pressure than the supply reservoir, or alternatively because of its extremely low flow rate, released into a waste reservoir 140.
  • the micro-flow reagent reservoir may contain multiple bags 20 of different kinds of chemical systems which allow the sensor to measure other target-chemicals by flowing the reactive-substance, e.g., an enzyme or reactive dye, through the microdialysis tubing attached to the sensor.
  • the additional reagent bags can be placed in a separate self-enclosed pressurized reservoir.
  • microvalves 40 which are commercially available from TiNi Alloy Co., located in San
  • Leandro, California are employed to switch between the various reagent bags so as to supply the sensor with a different chemical system.
  • These microvalves are in electrical communication with the computer micro-controller.
  • the micro-flow reagent reservoir may be remote from the sensor and connected to it by a catheter containing microbore tubing.
  • This system may desirably take the form of a small storage reservoir which contains a means for refilling it in the reservoir.
  • a typical system is illustrated in Figure 4.
  • the reservoir containing the enzyme or chemical system is remote in location from the sensor 220 and connected to it by a catheter 210 of suitable length containing the microbore tubing and electrical lead wires.
  • This system may desirably take the form of a small storage reservoir 200, perhaps of the size and shape of a pacemaker, which contains a means for refilling by way of a syringe needle through a septa 230 in the containment.
  • This system may be refilled in a way -17-
  • the sensing system in accordance with the invention results in dramatic improvement in the stability of the thermopile, and even other types of amperometric biochemical sensors, resulting from the constant renewal of the chemical reagent system.
  • the reagent is not limited to a fixed amount that is typically trapped behind a membrane, for example, as in the case with conventional enzymatic sensors. Enzymes and other organic chemical systems typically have longer shelf life compared to operational life, e.g., when in continuous contact with an environment having the target-chemical. Changes in the activity of the stored reagent over time typically do not have substantial effect on the senor operation. The period of reagent stability, of course, varies depending on the reagent system.
  • thermopile 80 sensor which is illustrated by Fig. 1 and Fig. 3, has several electrical contacts 110 and 111 which tap the series of thermoelectric junctions at fixed intervals. These taps are useful in combination with a hollow membrane microflow system whereby the enzyme moves progressively over the duration of its forward progress to a different set of thermoelectric junctions. The process is one whereby the new entering enzyme generates a greater heat for the thermoelectric junctions 110 more proximal to the new enzyme while the older and more decayed enzyme generates a lesser heat over the more distal thermoelectric junctions 111 along the flow stream.
  • thermoelectric signal 120 from the proximal sets of junctions which are in contact with the new entering enzyme, to the distal thermoelectric junctions whose signal 121 corresponds to that of an older and therefore more decayed activity, it is possible for the microcontroller 130 to estimate and thereby compensate for the rate of enzyme decay.
  • junctions are measured by an automated electrical or computer based system 130 so as to compare the relative activity of the enzyme just entering the membrane fiber at one end of the thermopile sets of junctions 110 to that at the other end 111 where the enzyme exits. The difference between these two signals can be used to estimate any changes in enzymes rate of decay in-situ and to effect a continual recalibration of the sensor.
  • the present invention includes (i) an optical cell and (ii) microdialysis tubing.
  • This sensing arrangement combines microdialysis sampling techniques with the use of a micro flow system employing an optical cell to create a system that can accurately measure the concentration of glucose and other chemicals in complex solutions bearing proteins.
  • This particular approach has advantages which allow its use in diverse applications, such as for cell culture biochemical measurement, as well as for implantable applications for blood glucose measurement.
  • the biochemical sensing system as illustrated by Fig.
  • a pressurized container 300 which includes collapsible bags, typically made of MYLAR, 304 for holding reagents, calibration solution 302, and sweep solution 306. These are regulated in their flow by resistance tubing, as hereinbefore described, whose diameter and length can been selected to achieve flow rates typically in the sub-microliter per minute regime. For example, a 25 centimeter length of 15 micron diameter silica resistance tubing, and with a 10 psi charging pressure in the container squeezing on the reagent bag will produce a flow rate of approximately 300 nl/minute.
  • the sweep solution is typically regulated to a flow rate which is slower by about 20-50 times, i.e., in the tens of nanoliter per minute rate, than the reagent in order to achieve a correct proportion in mixing.
  • the mixing ratios will differ according to a specific reagent, the mixing ratio reagent to sweep fluid for the Trinder test is from about 20:1 to about 200:1.
  • the sweep solution is introduced by connecting tubing, typically microbore tubing, to a microdialysis -19-
  • the target-chemical concentration in the sweep fluid can reach diffusive equilibrium with the test environment.
  • the return dialysate i.e., sweep fluid containing the target-chemical
  • the mixed solutions move down a single tube or capillary 330 where the chemical reaction of the reagent with glucose proceeds and the optical change occurs, i.e., the reagent-dialysate mixing volume.
  • the absorbance of the flow stream at the specific color of a chemically sensitive dye is measured by an optical cell 320 having a light emitting diode and miniature diode photodetector.
  • the resulting photodetector signal is calibrated in terms of glucose concentration by the microcontroller 340.
  • the microdialysis tubing 308, also referred to as a membrane hollow fiber, in contact with the test solution test is made from a material which is permeable to glucose but excludes large molecular weight materials.
  • the microdialysis tubing is made of materials such as cellulose acetate, polysulfone, and polyacrylonitrile, usually in the form of hollow tubes on the order of 200 microns in diameter.
  • the reagents that are mixed with the sweep fluid are chosen so that their color or fluorescence change has a specific response to the biochemical desired, as is well known in the art.
  • An optical cell 320 at the receiving end of the mixed reagent flow stream measures color or fluorescence change, and the signal obtained therefrom is related to chemical concentration by microcontroller 340.
  • a suitable optical cell is shown in Figure 7.
  • the optical cell includes a light transparent capillary tube 462 having a light emitting diode 464 and photodiode 466 placed on opposite sides outside of the capillary tube 462.
  • the optical cell 320 constructed of capillary tubing approximately 100 microns in diameter, mates directly to a Y-connector where mixing of the dialysate and the reagent occurs 330. For example, in the case of a -20-
  • Trinder based absorbance glucose sensor blue excitation light from a high intensity light emitting diode (LED 505 nm for Trinder test) passes through the developed dye in the optical flow cell.
  • the photodiode has a light approximately 0.5 mm square and is mounted directly against the capillary tubing.
  • the total volume of the developed reagent contributing to the detected absorbance signal is approximately 300-600 nl.
  • the electronics support system for the optical fluorescence cell includes an oscillator-driver which applies a square wave current to the blue LED for dye fluorescence excitation.
  • the absorbance is detected by the photodiode and is demodulated to determine its amplitude by a lock-in amplifier.
  • the test environment may be remote from the reagent reservoirs and the microdialysis sampling fiber connected to it by microbore tubing.
  • the diameter of the interconnecting tubing is preferably exceedingly small, typically 35 to 44 gauge, and short as possible so as to minimize the hold up volume and reduce its loop transit time back to the waste reservoir.
  • the optical cell volume of the capillary is typically on the order of about 100 nanoliters to about 1 micro liter.
  • An optimum mixing ratio can be experimentally determined by taking into account the trade-off between linearity at high dilutions versus reduced reagent consumption rate at low flow rates.
  • the mixing ratio of reagent to dialysate is determined by the respective flow rates of the dialysate and a particular reagent.
  • a Trinder reagent test employing the enzyme glucose oxidase is used to give a specific colorimetric response to glucose in the microdialyzed flow.
  • the mixing ratio of reagent flow to sweep flow is typically about 40: 1.
  • a toluidine based reagent for glucose is used and after mixing with the sweep fluid, is heated by passing it through a capillary tube heated by a resistance wire to 100°C required for color development.
  • the mixing ratio of toulidine flow to sweep flow is typically about 5:1. -21-
  • This invention can also advantageously employ multiple reagents for multiple analytes in combination with multiple optical cells which measure different optical properties of the mixed reagent system.
  • Each property e.g., absorbance or fluorescence
  • the reagents added to the incoming dialysate can alternate to serially determine the presence of multiple substances in the dialysate.
  • microvalves 360 can be used to turn on or turn off the flow rate of any of the reagents.
  • the colorimetric test is a robust approach to measuring chemical concentration and does not exhibit the problems of electrical drift that are common with electrochemical techniques.
  • amperometric electrodes experience slow changes in their platinum electrodes, enzymes, and silver reference electrodes.
  • the reagents for the optical cell typically have a longer shelf life than if they were in continuous contact with an environment containing the target-chemical. These chemical tests reach an endpoint where the absorbance reaches a final value. If enough time is allotted for development, the enzyme activity and its corresponding rate of development does not affect the accuracy of the measurement. In contrast, most other sensors depend on the rate (i.e., activity) of the enzymatic reaction to provide an accurate reading. There is little else about the system that is subject to aging effects.
  • this sensor approach continuously mixes fresh reagent from the supply reservoir with the microdialysis sample stream.
  • the flow streams can be shut off by the employment of microvalves 360. This can be advantageous where continuous monitoring is not required and it is desired to prolong the lifetime of the sensor reagent supply.
  • the mixture is carried by its flow past the optical cell 320.
  • the sensor system has a potentially long lifetime because (i) a relatively large amount of the optical reagents can be stored in a remote reservoir and (ii) slow flow rates are used. In comparison, most conventional electrodes contain -22-
  • Typical flow rates of the sweep fluid are on the order of 10-50 nl/min while the flow rate of the reagent is on the order of 100 nl to 1 microliter per minute. These flow rates allow month-order and longer continuous monitoring sensor operation with reagent reservoir volumes less than 25 milliliters.
  • the sensing arrangement according to the invention may be implanted to provide glucose sensing by introducing the microdialysis interface, as a catheter, to the portion of the body where it is desired to measure glucose concentration. This might be in the lumen of the heart, to a blood vessel using a suitable interface, or to the peritoneal cavity.
  • the reagent supply and optical readout would typically be implanted in a way similar to that of a pacemaker, as shown in Fig. 4.
  • the reagent supply reservoir and sweep fluid reservoir must be replenished periodically, typically by methods similar to the replenishment of insulin in implantable insulin delivery pumps. This is performed by the use of a coaxial syringe needle puncturing a septum on the reagent supply casing and refilling the distensible supply bag while using the second needle lumen to remove waste in accordance with the arrangement shown in Fig. 4.
  • Catheter style interfaces of the microdialyis fiber consist of integrating the microdialysis interface into the distal and surface of a catheter. Interconnection to the microdialysis fiber is by way of microbore tubing running through the catheter.
  • the sensor system for glucose resembles that of a pacemaker, and indeed might be implanted in a similar way to sample the glucose concentration in the blood of the heart via a catheter introduced into the heart in the same way as a pacemaker lead.
  • sampling of media is by way of a catheter made from silicone rubber containing a window exposing the membrane hollow fiber to the solution.
  • the sweep fluid is circulated by flow through the catheter loop and returns to mix with the reagent flow stream and than pass on to the optical cell.
  • another collapsible waste reservoir 350 that holds the developed reagent as a waste product that ultimately will be retrieved.
  • the microdialysis fiber is in direct contact with a flow stream of a cell culture media by employing a flow interface.
  • This interface need not be much more than a loop-through of the microdialysis fiber through the walls of a bioreactor or with a portion of the flow loop tubing such that the fiber comes into contact with the media.
  • Colored calibration fluids 302 which are insensitive to the target-chemical concentration (e.g., insensitive to glucose concentration) yet have known optical properties can be introduced into the loop periodically to verify the operation of the flow loop and optical cell operation.
  • the present sensing system also provides an arrangement for detecting a gas which includes (i) a optical cell and (ii) gas-permeable microdialysis tubing.
  • This embodiment combines optical principles for measuring oxygen and/or carbon dioxide in conjunction with a microflow system that circulates a gas sensitive reagent through a gas-permeable membrane hollow fiber that is placed in contact with a test medium.
  • the sensors described in Towe et al., "A recirculating-flow fluorescent oxygen sensor,” Biosensors & Bioelectronics. Vol. 11, No. 8, pp. 799- 803 (1996), which is incorporated herein by reference, can used according to the present embodiment.
  • gas sensitive reagents are circulated through microbore tubing 430 up the length of a catheter 435 to a gas-permeable hollow membrane fiber 440 at its end which is exposed to the blood or solution under test 450.
  • the membrane hollow fiber is made from silicone or other gas permeable material which excludes diffusion therethrough of dissolved non-gas substances, thereby preventing contact of the non-gas substances with the reagent.
  • the returning reagent flow stream is in equilibrium with the gas concentration at the sensor tip and affects the optical properties of the reagent.
  • the reagents circulated are chosen so that their color or fluorescence change in specific response to the gas desired.
  • the signal derived from the optical cell is related to chemical concentration by a microprocessor.
  • Silicone tubing being relatively permeable to gases (i.e., oxygen and especially carbon dioxide) yet hydrophobic, can effectively entrap liquid solutions of reagents and gas-sensitive dyes while preventing their diffusion into the test media, e.g., a blood flow stream.
  • a single loop of the silicone tubing can alternately measure either oxygen or carbon dioxide while in situ without replacing the catheter or need for a second flow loop by alternately infusing the corresponding optically responsive reagent in the tubing loop.
  • This kind of sensor strategy permits a longer dye lifetime than fiber optic approaches since (i) the optical reagents are constantly renewed at a relatively low flow rate and (ii) the relatively large amount of the dye can be stored in a remote reservoir.
  • the optical signal derived from the reagent is relatively larger compared to that obtained, for example, from fiber optic systems because of the larger volume of fluid, as much as ten times, being illuminated at the optical cell. This typically results in good signal to noise ratios.
  • the sensing reagent is subjected to a lower intensity of light for fluorescence or absorbance tests because of the relatively higher signal level. Hence problems with reagent bleaching due to continuous exposure to intense light do not affect the present sensor operation to the extent of the prior art sensors.
  • Colored calibration fluids not shown in Fig. 6, which are insensitive to the target gas concentration yet have known optical properties can be introduced into the loop periodically to verify the operation of the flow loop and optical cell operation.
  • oxygen concentration can be determined by measuring fluorescence of an oxygen quenched dye exiting a thin silicone tube which is immersed in the test solution.
  • the flow rate of the dye is slow enough so that the oxygen concentration in the dye solution achieves diffusive equilibrium across the -25-
  • a preferred silicone tubing is #508-001 available from VWR Scientific Products, Salt Lake City, Utah, and typically has an outer diameter of about 1.65 mm, an inner diameter of about 0.76 mm, and a length of about 0.5-1.0 cm.
  • the flow rate of the dye through the tubing is typically in the range from about 300 nl/min to about 1 ⁇ l/min. Partial pressure equilibrium of oxygen occurs through the wall of the tubing in residence times of a minute or so as a result of the high permeability 50 x 10 "9 cmVsec cm 2 cm-Hg of silicone for oxygen as described in the product information for Zero Corp, located in North Salt Lake, Utah (1993).
  • the outlet flow of a pressurized reservoir of fluorescent reagent 410 is regulated by employing a length of 15-25 ⁇ m silica resistance tubing 420 having an inner diameter of about 15-25 nm.
  • a length of 15-25 ⁇ m silica resistance tubing 420 having an inner diameter of about 15-25 nm.
  • the optical fluorescence cell 460 is constructed of glass, TEFLON, or quartz capillary tubing 462 approximately 100 microns in diameter and mates directly to the silicone tubing entering into the sensor body.
  • Blue excitation light from a high intensity blue light emitting diode (LED) 464 passes through the dye in the optical flow cell. It is typically blocked from direct illumination of the photodetector by a broad bandpass red celluloid filter, not shown, that transmits the dye fluorescence at 620 nm and blocks the blue excitation source.
  • the photodiode sensitive area 466 is approximately 0.5 mm -26-
  • the total volume of the dye contributing to the detected fluorescence signal is approximately 0.5 ⁇ l.
  • the electronics support system for the optical fluorescence cell consists of an oscillator-driver which applies a 400 Hz square wave current to the blue LED 464 for dye fluorescence excitation.
  • the time varying fluorescence is detected by the photodiode 466 and is demodulated to determine its amplitude by a lock-in amplifier.
  • the oxygen-quenching fluorescent dye ruthenium tris- (2,2'-bipyridyl) II dichloride (RTDP, formula weight 640.5) is used in the present gas sensors. It's use was reported in Wolfbeis, et al., "Fiber Optic Flurosensor for Oxygen and Carbon Dioxide," Anal. Chem.. 60:2018 (1988) and Wolfbeis et al., "Recent Progress in Optical Sensor Design," Proc. SPIE. 906:42 (1988).
  • Other fluorescent dyes sensitive to oxygen are known to the art and can be used herein.
  • the oxygen sensor uses an oxygen-sensitive fluorophore, e.g., tris (2,2,'-bipyridine)-ruthenium(II) chloride perfused at 10 ⁇ l/min. through a 14 cm silicone hollow fiber membrane (0.305 mm i.d. x 0.508 mm. o.d.).
  • a 470 nm LED available from Panasonic LNG992CFBW, excites the 463 nm excitation peak of the fluorophore through a 0.635 mm translucent capillary.
  • the 620 nm peak is monitored with an orange coated (Orange Poppy transparent glass paint available from Plaid Enterprises Inc.) photodetector which is available from Texas Instruments TSL 235.
  • a catheter made from a gas impermeable tubing connects to a gas permeable segment in a region where the gas concentration is to be measured.
  • the dye is circulated by flow through the catheter loop and returns to pass through the optical cell.
  • the two types of tubing can be interconnected using any means known in the art, such as via a short length of stainless steel tubing, e.g., syringe needle, placed within the lumens of the two tubing, or via a coaxial press fit of two different sized tubings, typically secured by a silicone glue.
  • Measurement of a gas such as carbon dioxide tension may advantageously be performed by way of a phenol red dye in a bicarbonate buffer solution which is circulated through the hollow membrane fiber at the end of the catheter.
  • This solution changes color specifically in response to carbon dioxide concentration and its properties and composition are well known to the art.
  • the returning flow from the catheter tip is subjected to a light of a 535 nm wavelength, typically generated by a light emitting diode; its absorbance at this wavelength is measured by a photodiode; and the resulting signal is calibrated to carbon dioxide concentration.
  • the silicone tubing is particularly permeable to carbon dioxide, and so is a suitable hollow membrane fiber. It allows the reagent solution to respond selectively to carbon dioxide without interference from the pH of the test solution or other substances in the environment.
  • the response time of this sensing arrangement is determined primarily by the flow rate of the dye and the length and hold up volume of the tubing in the return flow loop. For this reason, it is desirable to use very small diameter fluid- return tubing, such as number 36-40 gauge tubing to minimize this delay.
  • This sensor is excellent; generally maintaining within +/- 1% of its initial reading after exposure to a transient change in oxygen tension. No measurement hysteresis, or unaccountable baseline shift is typically observed, and the reagents do not exhibit time-dependent changes in their sensitivity or other characteristics.
  • Flow-type sensors transport microquantities of oxygen by diffusion through the silicone tubing wall to or from the immersion solution. These small quantities can affect the sensor performance by creating an oxygen boundary layer build-up phenomena around the silicone tubing and changing the oxygen concentration in the local microenvironment next to the tubing. Without wanting to be limited by any one theory, it is believed that the sealed feed reservoir of fluorophore circulating solution brings with it a potentially different concentration of oxygen -28-
  • a sensing arrangement in another embodiment, includes a glucose sensor that employs a commercial e-PTFE vascular graft modified to incorporate a microdialysis fiber as an interface to the blood stream.
  • the low flow rate of a sweep fluid from the sweep fluid reservoir allows the target chemical to enter the sweep fluid via diffusion from the blood stream through the e-PTFE vascular graft and the microdialysis fiber.
  • the dialysate containing the target chemical at the concentration of the blood stream emerges from the fiber and continuously mixes with another microflow stream containing a colorimetric reagent.
  • Glucose concentration is subsequently monitored by absorbance changes in the mixed flow by using a small optical absorbance cell having a light emitting diode and a photo detector.
  • Example 1 Implantable Microfluidic Glucose Sensor An implantable microfluidic glucose sensor 500 is shown in Fig. 8.
  • This pacemaker-like device includes a containment 550 having a compartment housing a sweep fluid reservoir 554 and a reagent reservoir 556 connected by microbore tubing 558 to the microdialysis tubing 520 which is fixedly attached and in diffusive contact with a e-PTFE sheath 510.
  • the e-PTFE sheath is in fluid contact with the sample test media.
  • the optical cell 540 includes a capillary tube having a light emitting diode (LED) 542 on one side and a photodetector 544 on the other side is housed in a second compartment which incudes telemetry equipment.
  • LED light emitting diode
  • a waste fluid reservoir 560 is housed at a lower pressure than the compartment housing the sweep fluid and the reagent.
  • the waste fluid reservoir is typically placed outside the containment which is pressured with perfluorocarbon propellant 552.
  • the waste fluid reservoir 560 can also be covered by an expandable biocompatible material 570.
  • Example 2 Sensing Arrangement Including Vascular Interface A sensing arrangement as shown in Fig. 9 including a vascular interface 600 was used to measure glucose concentration.
  • the sensing arrangement also included a syringe pump 610, a development tube 620, a roller pump 630, reservoir 640, an optical cell 650, a microcontroller 660 and a personal computer 670.
  • the vascular interface 600 includes dialysis fiber 602 within the lumen of a e-PTFE tube 604.
  • the development tube 620 is 0.065" (1.65 mm) in diameter and approximately 10 cm long.
  • the Trinder reagent flows from a first syringe 612 directly into the development tube 620 via microbore tubing.
  • the sweep fluid coming from a second syringe 611 also driven by the syringe pump, passes by way of microbore tubing to the microdialysis fiber 602 embedded within the vascular graft interface 600.
  • the dialysis fiber exit is mated to a microbore -30-
  • the polyimide tube that carries the dialysate to the development tube 620.
  • the two flow streams meet at the entrance of the development tube and proceed to mix together as they proceed by flow to progress down the tube.
  • the optical cell 650 is placed so that it views the flow stream at 4.1 cm downstream from the point where the Trinder reagent and the diasylate sweep fluid meet.
  • the flow fransit time to arrive at the optical cell provides time for the chemical reaction of the Trinder reagent and sweep fluid to fully develop and achieve maximal absorbance.
  • the microdialysis fiber was prepared as follows.
  • a regenerated cellulose (RC) fiber was extracted from a Terumo Clirans 220 hemodialyzer manufactured by the cuproammonium rayon method.
  • the inner diameter of the dialysis fiber was 200 ⁇ m
  • the wall thickness was 9 ⁇ m
  • the molecular weight cutoff i.e., for a target chemical able to diffuse therethrough
  • the fibers were prepared by first removing a single dialysis fiber from the dialyzer, cropping the fiber to a length of 6 cm and then inserting a 100 ⁇ m platinum wire into the fiber lumen to allow easier handling and to add structural support.
  • the dialysis fiber was secured to the e-PTFE using a silicone adhesive 705.
  • the dialysate inlet 706 and outlet 708 are also shown. Approximately 1.5 cm of its length was exposed to the test solution flowing through the graft.
  • the dialysis fiber 700 was placed within the thickness of the e-PTFE wall of the graft 702. This was accomplished by thinning down a portion of the graft wall with a sharp razor blade so that a layer (0.5mm) of the wall remained.
  • the slit was approximately 3.5 cm long and 0.5 cm wide.
  • a microdialysis fiber was placed on the cut down region and a 1 x 4 cm piece of polyethylene film 704 was used to seal in the fiber and add support.
  • a cyano-acrylate glue was used to secure the polyethylene film.
  • a variation of this arrangement involved additionally perforating the thinned graft wall with a 25 -gauge hypodermic needle to enhance diffusion. Approximately 25 punctures where evenly spaced over the 3.5cm length. This enhanced filtration of fluid from the lumen. This configuration was used to maximize transport and test the response of other parts of the sensor system.
  • This sensor arrangement flows distilled water through the microdialysis fiber. Glucose diffuses or dialyzes across the membrane from the bulk media. As shown in Fig. 9, the dialysate then flows into a larger diameter and several centimeter long developer tube 620 where there is added a flow of glucose- sensitive Trinder reagent available from Sigma Inc. Mo. The colorimetric absorbance is measured as the flow moves into a glass capillary acting as an optical cell 650.
  • Flow of the dialysate was at 263 nl/min and the Trinder reagent at lO ⁇ L/min.
  • the length of the development tube was chosen such that there was a delay of approximately 10 minutes for the dye to develop prior to reaching the optical cell.
  • the dye absorbance was measured by passing the development tube between a 505 nm LED (LEDtronics Inc, USA) opposite a pre-amplified photodetector (OPT 201, Burr-Brown, Arlington, AZ). The amount of light that reaches the photodetector is a function of the sample absorbance.
  • Example 2 The sensing system of Example 2 was tested and calibrated with glucose buffer standards flowing through the vascular interface at 30 ml/min.
  • the first configuration where the fiber was located along the wall of the graft, calculations show that sweep fluid residence times of thirty seconds resulted in a 90% equilibration with the surrounding bulk flow.
  • the residence time needed to achieve 90% equilibrium extended to 220 seconds.
  • Glucose diffusion through thinned e-PTFE walls but not perforated did not achieve equilibrium with the sweep flow in any reasonable residence time tested. Manual methods were not successful in thinning the wall much more than 500 microns. It may be that other types of graft materials are more permeable.
  • the effect of different mixing ratios of the dialysis sweep fluid flow to the reagent system flow can be used to determine the optimum mixing ratio.
  • Lower dilution ratios result in a desirably higher sensitivity to glucose but result in reduced range of linear response.
  • Lowered ratios were also found to make the system sensitive to irregularities in flow rates and proportioning errors from syringe pumps that were operated below their rated flow rates.
  • Ten-minute development times resulted in a stable color change that translated to a glucose uncertainty of ⁇ 5mg/dL.
  • the 38:1 dilution ratio used allows for a linear range up to 300mg/dL.
  • Fig. 11 The glucose concentration of the bovine blood was increased by stepwise addition of powdered glucose to the flow loop. The decrease in glucose concentration was caused by replacing the circulating blood with fresh blood that had the original concentration. The average response time was 16 minutes, consisting of approximately a 12-minute pure delay due to various fluidic hold up volumes and a rise time of 4 minutes and a decay time of 5 minutes. Fig. 11 also demonstrates the glucose sensor system is quite accurate, i.e., +/- 5%, and is able to measure glucose concentration in a complex solution like bovine blood.
  • Microdialysis sensors consume their substrate. Glucose in the local environment diffuses through the membrane fiber and is transported away from the site by flow. As a result, the rate of diffusion of glucose to the sensor site must be faster than its removal by the dialysis fiber to allow the sensor to reflect the concentration of the test solution. Additionally, the sensor system depends on the emerging sweep fluid concentration to be in essential equilibrium with the surrounding glucose value. This means that the sweep fluid must flow through the fiber slow enough to achieve a relatively high extraction fraction (E), which is the ratio of target chemical concentration in the dialysate and the target chemical concentration in the test medium, given by the following equation:
  • QR where Q is the flow rate of the dialysate and R is the resistance to analyte diffusion into fiber. This resistance in turn depends on not only the membrane hollow fiber resistance, but also that of any overlying layer of PTFE, as well as on the fluid convective environment around the fiber.
  • the sensing system When the membrane fiber is placed in the lumen of an e-PTFE graft the sensing system performs adequately and at a given sweep flow rate the extraction -34-
  • Fig. 12 illustrates residence times using alternately a regenerated cellulose (RC) microdialysis fiber or AN69 microdialysis fiber when specifically placed within a perforated pocket and within 0.5 mm of the inside wall of the e-PTFE vascular graft in accordance with Example 2.
  • This plot illustrates the slowing down of the equilibration process due to the increased resistance of the e-PTFE to diffusion of glucose therethrough.
  • the Trinder reagent darkens with increasing concentration of glucose added.
  • Fig. 13 shows that at high dilution ratios (e.g., 200:1) the sensitivity is relatively low since the changes in absorbance with glucose concentration are relatively small. At lower dilution ratios, the sensitivity is higher but the readings at different concentration suffer from nonlinearity resulting from the smaller change in absorbance at higher concentrations of glucose.
  • the actual dilution ratio used was 38:1 which was a compromise between sensitivity and linearity.
  • Example 6 Determination of Optimum Residence Time An experiment directed to determining the fraction of glucose equilibrium to the sampled solution versus the residence time of a saline sweep fluid in a cellulose acetate hollow membrane fiber was performed as follows.
  • FIG. 14 A plot of these ratios is shown in Fig. 14.
  • the graph shows, for the specific Cuprophane membrane shown, that the sweep fluid within the fiber achieves greater than 95% diffusive equilibrium with the glucose concentration in the flow stream in times equal to or greater than 150 seconds. This experimental result defines the flow rate through the microdialysis fiber needed to achieve adequate -36-
  • the membrane fiber is brought into contact with blood, cell culture broth, or other media or material containing glucose that is diffusible across the membrane fiber whose concentration is to be monitored.
  • This sensing arrangement used a 5 cm length of small diameter silicone tubing (0.305 mm i.d. x 0.61 mm o.d., Dow Corning Inc.) through which a sweep fluid was passed at 3.8 nl/min.
  • the sweep fluid consisted of a 0.04 wt% phenol red in a 35 mM bicarbonate buffer.
  • This solution is known to the art as a concentration indicator and has the property of changing its absorbance in proportion to the dissolved CO 2 over a range of concentrations that are of interest in biological and living systems.
  • the silicone tubing with the indicator sweep fluid acts as the primary sensor element.
  • the sensor system response to CO 2 was measured by placing it in a coaxial countercurrent flow stream of water moving past it at a velocity of approximately 3 cm/sec.
  • the CO 2 concentration of this flow stream was adjusted by an external system employing a membrane gas device that is well known to those in the art.
  • the residence time for the sweep fluid in the silicone tubing was 1.05 minutes. Silicone tubing is highly permeable to CO 2 , and it was found that residence times greater than approximately 30 seconds were adequate with the employed silicone tubing to ensure greater than 95% CO 2 diffusive equilibrium with the surrounding flow stream. The approximately one minute residence time actually employed was used as an extra margin of safety to insure nearly total CO 2 equilibrium with the surrounding flow stream. This was also done to minimize changes in the system calibration as the silicone tube becomes coated with contaminants carried by the measured flow stream that may tend to adhere to the tubing and reduce CO 2 diffusion across the membrane. -37-
  • the optical absorbance of the emerging sweep fluid was measured by flowing it through a 0.635 mm diameter glass capillary tube and placing a 555 nm (green) light emitting diode and a standard photodetector diode (Burr Brown OPT- 201) across the flow stream. Variations in the absorbance of the sweep fluid are proportional to CO 2 concentration and these cause a greater or lesser amount of light to fall on the photodetector. The output voltage of the photodetector is thereby proportional to the CO 2 concentration. This electrical voltage is subsequently signal processed by a microcomputer system to linearize the response. There follows a conversion of the voltage to a chemical concentration value through a computer based calibration look-up table as is common in the art. A plot of the output voltage versus CO 2 pressure is shown in Fig. 15.
  • Example 8 Determination of Optimum Glucose Response Range
  • a microdialysis fiber was constructed by introducing a 3.5 cm long loop of 200 micron i.d. (628 nl total volume) Cuprophane dialysis fiber available from Enka, Inc. into a coaxial countercurrent circulating flow stream of buffer test solution pumped at a flow velocity of 2.1 cm/second past the fiber.
  • the glucose concentration of the solution was an experimental variable and adjusted by adding glucose to the circulating solution in quantities sufficient to achieve the required concentration increments shown.
  • a pump was used to pass a water sweep fluid through the dialysis fiber at a flow rate of 263 nl/min such that the residence time of the sweep flow within the fiber was 4.1 minutes. As shown in Fig. 14 this resident time was found sufficient to achieve greater than 98% diffusive glucose equilibrium with the surrounding flow stream.
  • both tubes were aligned so that both flow streams entered the capillary at the same point.
  • the mixing ratio of these two streams is determined by their relative flow rates. In this example, a mixing ratio of 38:1 was chosen.
  • This dilution ratio was selected as a compromise between linearity of response with increasing glucose concentration, sensitivity, and consumption rate of the reagent. Higher dilution ratios, up to 200: 1 are recommended by the manufacturer to maximize range of linear absorbance change with concentration. Lower dilution ratios cause a greater absorbance change for a given concentration change and thus increase sensitivity.
  • Lower dilution ratios also reduce the flow rate of the Trinder in proportion to the sweep flow and so desirably reduce the consumption rate and storage volumes of the Trinder.
  • the optical cell was placed 4.6 cm downstream of the mixing point of the reagent and dialysate such that the transit time to the cell equaled about ten minutes. This interval gave sufficient time for intermixing and a chemical reaction process to occur that resulted in the darkening of the Trinder reagent in accordance with the manufacturer's development time specification.
  • the optical absorbance of the flow stream was measured by placing a 505 nm (blue-green) light emitting diode and a standard photodetector diode (Burr Brown OPT-201) across the photodetector such that the flow stream intercepted the light path. This color was chosen to match the color of maximal absorbance of the Trinder indicator. After passing the optical cell, the flow stream continues on to a waste container. -39-
  • the photodetector was arranged and baffled such that only transmitted light through the flow stream fell on its photosensitive surface.
  • a variation in the absorbance of the flow stream is proportional to glucose concentration and this causes a greater or lesser amount of light to fall on the photodetector.
  • the output voltage of the photodetector is thereby proportional to the glucose concentration.
  • This electrical voltage is subsequently signal processed by a microcomputer system to linearize the response. There follows a conversion of the voltage to a chemical concentration value through a computer based calibration look-up table as is common in the art. A plot of the output voltage versus glucose concentration is shown in Fig. 16.
  • the sensing system has a response time which can be reduced by adjusting a number of variables.
  • the 30 second and 220-second sweep fluid residence times are defined by the convective environments and are relatively fixed.
  • the typically ten-minute development time for the reagent is defined by the use of Trinder reagent. Additions of glucose oxidase to this standard test can reduce the development time to less than five minutes.
  • the lengths of the interconnecting tubing creating hold-up volume delays are the remaining factors contributing to the overall approximately 16 minute response time. With some effort these contributions might be reduced to near zero. This would result in a sensing arrangement whose response time is the sum of the development time and the sweep fluid residence time; perhaps on the order of five to seven minutes.

Abstract

L'invention concerne un système de détection implantable offrant une stabilité à long terme. Ce système, qui fait appel aux techniques d'échantillonnage en microdialyse, comprend un réservoir de microflux (10a) ayant un réactif capable de réagir avec un produit chimique cible, et un capteur (80a) relié au réservoir de microflux (10a). Ledit capteur, qui permet de déceler la réaction entre le réactif et le produit chimique cible, peut renfermer une thermopile (80) ou une cellule optique.
PCT/US1999/002493 1998-02-04 1999-02-04 Capteurs chimiques a systemes de microflux WO1999039629A1 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US7365198P 1998-02-04 1998-02-04
US7365298P 1998-02-04 1998-02-04
US7365398P 1998-02-04 1998-02-04
US60/073,651 1998-02-04
US60/073,652 1998-02-04
US60/073,653 1998-02-04

Publications (1)

Publication Number Publication Date
WO1999039629A1 true WO1999039629A1 (fr) 1999-08-12

Family

ID=27372322

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/002493 WO1999039629A1 (fr) 1998-02-04 1999-02-04 Capteurs chimiques a systemes de microflux

Country Status (1)

Country Link
WO (1) WO1999039629A1 (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003003911A2 (fr) * 2001-07-06 2003-01-16 Lukas Schaupp Procede pour mesurer la concentration de substances dans des organismes vivants par microdialyse et dispositif pour mettre en oeuvre ce procede
WO2005111629A1 (fr) * 2004-05-17 2005-11-24 Danfoss A/S Appareil de microanalyse avec systeme de pompe a pression constante
WO2006006795A1 (fr) * 2004-07-09 2006-01-19 Korbi Co., Ltd. Appareil pour maintenir une temperature constante dans des instruments de mesure de qualite de l'eau
WO2008089766A1 (fr) 2007-01-26 2008-07-31 Diramo A/S Système d'analyse équipé d'une unité d'analyse à distance
WO2008089764A1 (fr) 2007-01-26 2008-07-31 Diramo A/S Capteur pour système d'analyse
WO2011085728A1 (fr) 2010-01-13 2011-07-21 Flowsion Aps Système micro-fluidique comprenant un dispositif d'émission de lumière
WO2012062320A1 (fr) 2010-11-10 2012-05-18 Flowsion A/S Système d'analyse microfluidique avec réservoir à déchets sous pression
US8192360B2 (en) 2007-09-25 2012-06-05 Pacesetter, Inc. Implantable body fluid analyzer

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878049A (en) 1973-04-03 1975-04-15 Massachusetts Inst Technology Biochemical temperature-sensitive probe and method for measuring reactant concentrations thereof
US3972681A (en) 1975-07-14 1976-08-03 Leeds & Northrup Company Flow-through thermal detector
US4021307A (en) 1974-06-07 1977-05-03 Lkb-Produkter Ab Method and apparatus for measuring temperature changes generated by enzyme activity
US4685463A (en) * 1986-04-03 1987-08-11 Williams R Bruce Device for continuous in vivo measurement of blood glucose concentrations
WO1989002720A1 (fr) * 1987-10-05 1989-04-06 Rijksuniversiteit Te Groningen Procede, systeme et ensemble a cellule de mesure pour dosage de glucose
US4935534A (en) 1988-03-31 1990-06-19 Bayer Aktiengesellschaft 1-(N-formylamino)-2,4-dicyanobutane and a process for its production
US4935345A (en) * 1987-04-07 1990-06-19 Arizona Board Of Regents Implantable microelectronic biochemical sensor incorporating thin film thermopile
US5237993A (en) * 1987-02-02 1993-08-24 Avl Medical Instruments Ag Process and device for determining parameters of interest in living organisms
US5434084A (en) * 1989-09-06 1995-07-18 The Washington Research Foundation Flow optrode having separate reaction and detection chambers
US5640954A (en) * 1994-01-19 1997-06-24 Pfeiffer; Ernst Method and apparatus for continuously monitoring the concentration of a metabolyte

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3878049A (en) 1973-04-03 1975-04-15 Massachusetts Inst Technology Biochemical temperature-sensitive probe and method for measuring reactant concentrations thereof
US4021307A (en) 1974-06-07 1977-05-03 Lkb-Produkter Ab Method and apparatus for measuring temperature changes generated by enzyme activity
US3972681A (en) 1975-07-14 1976-08-03 Leeds & Northrup Company Flow-through thermal detector
US4685463A (en) * 1986-04-03 1987-08-11 Williams R Bruce Device for continuous in vivo measurement of blood glucose concentrations
US5237993A (en) * 1987-02-02 1993-08-24 Avl Medical Instruments Ag Process and device for determining parameters of interest in living organisms
US4935345A (en) * 1987-04-07 1990-06-19 Arizona Board Of Regents Implantable microelectronic biochemical sensor incorporating thin film thermopile
WO1989002720A1 (fr) * 1987-10-05 1989-04-06 Rijksuniversiteit Te Groningen Procede, systeme et ensemble a cellule de mesure pour dosage de glucose
US4935534A (en) 1988-03-31 1990-06-19 Bayer Aktiengesellschaft 1-(N-formylamino)-2,4-dicyanobutane and a process for its production
US5434084A (en) * 1989-09-06 1995-07-18 The Washington Research Foundation Flow optrode having separate reaction and detection chambers
US5640954A (en) * 1994-01-19 1997-06-24 Pfeiffer; Ernst Method and apparatus for continuously monitoring the concentration of a metabolyte

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
FULTON, ET AL.,: ""THERMAL ENZYME PROBE WITH DIFFERENTIAL TEMPERATURE MEASUREMENTS IN A LAMINAR FLOW-THROUGH CELL,"", ANALYTICAL CHEMISTRY,, vol. 52, no. 3, March 1980 (1980-03-01), pages 505 - 508
GUILBAULT,: ""FUTURE OFBIOMEMBRANE PROBES,"", THEORY, DESIGN AND BIOMEDICAL APPLICATIONS OF SOLID STATE CHEMICAL SENSORS,, 1978, CRC PRESS., pages 193 - 204
KECK ET AL.,: ""Combination of microdialysis and glucosenor permits continuous (on line)sc.glucose monitoring in a patient operated device:II evaluation in animals,"", HORM. METAB. RES., no. 24, 1992, pages 492 - 493
KECK ET AL.,: ""combination of microdialysis and glucosensor permits continuous (on line)s.c. glucose monitoring in a patient operrated device:I in vitro evaluation ,"", HORM. METAB. RES., no. 23, 1991, pages 617 - 618
TOWE ET AL.: "A recirculating-flow fluorescent oxygen sensor", BIOSENSORS AND BIOELECTRONICS, vol. 11, no. 8, 1996, gb, pages 799 - 803, XP002105441 *

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003003911A2 (fr) * 2001-07-06 2003-01-16 Lukas Schaupp Procede pour mesurer la concentration de substances dans des organismes vivants par microdialyse et dispositif pour mettre en oeuvre ce procede
WO2003003911A3 (fr) * 2001-07-06 2003-05-01 Lukas Schaupp Procede pour mesurer la concentration de substances dans des organismes vivants par microdialyse et dispositif pour mettre en oeuvre ce procede
US7022071B2 (en) 2001-07-06 2006-04-04 Lukas Schaupp Method for measuring the concentration of substances in living organisms using microdialysis and a device for carrying out said method
WO2005111629A1 (fr) * 2004-05-17 2005-11-24 Danfoss A/S Appareil de microanalyse avec systeme de pompe a pression constante
WO2006006795A1 (fr) * 2004-07-09 2006-01-19 Korbi Co., Ltd. Appareil pour maintenir une temperature constante dans des instruments de mesure de qualite de l'eau
WO2008089766A1 (fr) 2007-01-26 2008-07-31 Diramo A/S Système d'analyse équipé d'une unité d'analyse à distance
WO2008089764A1 (fr) 2007-01-26 2008-07-31 Diramo A/S Capteur pour système d'analyse
US8192360B2 (en) 2007-09-25 2012-06-05 Pacesetter, Inc. Implantable body fluid analyzer
WO2011085728A1 (fr) 2010-01-13 2011-07-21 Flowsion Aps Système micro-fluidique comprenant un dispositif d'émission de lumière
WO2012062320A1 (fr) 2010-11-10 2012-05-18 Flowsion A/S Système d'analyse microfluidique avec réservoir à déchets sous pression

Similar Documents

Publication Publication Date Title
US4832034A (en) Method and apparatus for withdrawing, collecting and biosensing chemical constituents from complex fluids
Tusa et al. Critical care analyzer with fluorescent optical chemosensors for blood analytes
Updike et al. Implanting the glucose enzyme electrode: problems, progress, and alternative solutions
EP0215678B1 (fr) Capteur biologique implantable contenant du gaz et procédé pour mesurer un analyte tel que le glucose
Frost et al. Implantable chemical sensors for real-time clinical monitoring: progress and challenges
Alcock et al. Continuous analyte monitoring to aid clinical practice
EP1739415B1 (fr) Procédé de restauration des proprietées fonctionelles d'un capteur électrochimique
JP3507448B2 (ja) 体液中の被分析物濃度を決定するシステム
EP1005566B1 (fr) Regeneration de biocapteurs
US4172770A (en) Flow-through electrochemical system analytical method
Wientjes Development of a glucose sensor for diabetic patients
US4311789A (en) Method for sampling and measuring the content of a low-molecular weight compound in a complex fluid medium
JPH08500679A (ja) 生体液の分析用校正液およびその使用方法
Meyerhoff In vivo blood-gas and electrolyte sensors: Progress and challenges
Fogt Continuous ex vivo and in vivo monitoring with chemical sensors
US4229542A (en) Apparatus for the measuring of the concentration of low-molecular compounds in complex media
Liu Electrochemical sensors
US7790438B2 (en) Apparatuses and methods for detecting an analyte
Pasic et al. Fiber-optic flow-through sensor for online monitoring of glucose
WO1999039629A1 (fr) Capteurs chimiques a systemes de microflux
Rolfe In vivo chemical sensors for intensive-care monitoring
Cooney et al. Optical pH, oxygen and carbon dioxide monitoring using a microdialysis approach
Walt Fiber-optic sensors for continuous clinical monitoring
Petrou et al. BioMEMS device with integrated microdialysis probe and biosensor array
Misiano et al. Current and future directions in the technology relating to bedside testing of critically III patients

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA JP KR MX US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 09600947

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: KR

122 Ep: pct application non-entry in european phase